- Home
- TDF vs SMTI Comparison
TDF vs SMTI Comparison
Compare TDF & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDF
- SMTI
- Stock Information
- Founded
- TDF 1994
- SMTI 1982
- Country
- TDF Singapore
- SMTI United States
- Employees
- TDF N/A
- SMTI N/A
- Industry
- TDF Finance/Investors Services
- SMTI Medical/Dental Instruments
- Sector
- TDF Finance
- SMTI Health Care
- Exchange
- TDF Nasdaq
- SMTI Nasdaq
- Market Cap
- TDF 244.7M
- SMTI 273.6M
- IPO Year
- TDF N/A
- SMTI N/A
- Fundamental
- Price
- TDF $9.72
- SMTI $27.28
- Analyst Decision
- TDF
- SMTI Strong Buy
- Analyst Count
- TDF 0
- SMTI 2
- Target Price
- TDF N/A
- SMTI $49.50
- AVG Volume (30 Days)
- TDF 79.2K
- SMTI 35.4K
- Earning Date
- TDF 01-01-0001
- SMTI 08-11-2025
- Dividend Yield
- TDF N/A
- SMTI N/A
- EPS Growth
- TDF N/A
- SMTI N/A
- EPS
- TDF N/A
- SMTI N/A
- Revenue
- TDF N/A
- SMTI $91,569,883.00
- Revenue This Year
- TDF N/A
- SMTI $23.53
- Revenue Next Year
- TDF N/A
- SMTI $5.93
- P/E Ratio
- TDF N/A
- SMTI N/A
- Revenue Growth
- TDF N/A
- SMTI 34.65
- 52 Week Low
- TDF $7.15
- SMTI $25.86
- 52 Week High
- TDF $10.62
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- TDF 50.36
- SMTI 33.24
- Support Level
- TDF $9.68
- SMTI $27.60
- Resistance Level
- TDF $10.13
- SMTI $30.36
- Average True Range (ATR)
- TDF 0.14
- SMTI 1.16
- MACD
- TDF -0.03
- SMTI -0.15
- Stochastic Oscillator
- TDF 42.19
- SMTI 7.78
About TDF Templeton Dragon Fund Inc.
Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invests in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables and many others.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.